Freedom Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-32,990
Closed -$594K 822
2024
Q3
$594K Sell
32,990
-1,660
-5% -$29.9K 0.05% 377
2024
Q2
$563K Buy
+34,650
New +$563K 0.05% 402
2021
Q1
Sell
-11,014
Closed -$106K 909
2020
Q4
$106K Sell
11,014
-6,608
-37% -$63.6K 0.01% 599
2020
Q3
$159K Sell
17,622
-20,629
-54% -$186K 0.02% 515
2020
Q2
$472K Buy
38,251
+16,870
+79% +$208K 0.05% 290
2020
Q1
$260K Buy
21,381
+283
+1% +$3.44K 0.02% 551
2019
Q4
$207K Buy
21,098
+5,654
+37% +$55.5K 0.02% 609
2019
Q3
$106K Sell
15,444
-2,490
-14% -$17.1K 0.01% 662
2019
Q2
$166K Sell
17,934
-1,967
-10% -$18.2K 0.01% 647
2019
Q1
$312K Buy
19,901
+360
+2% +$5.64K 0.03% 505
2018
Q4
$301K Sell
19,541
-1,428
-7% -$22K 0.02% 576
2018
Q3
$476K Buy
20,969
+358
+2% +$8.13K 0.03% 532
2018
Q2
$501K Buy
+20,611
New +$501K 0.03% 553
2017
Q3
Sell
-10,967
Closed -$364K 1148
2017
Q2
$364K Buy
10,967
+1,246
+13% +$41.4K 0.02% 695
2017
Q1
$312K Sell
9,721
-1,147
-11% -$36.8K 0.02% 746
2016
Q4
$394K Sell
10,868
-28,179
-72% -$1.02M 0.02% 576
2016
Q3
$1.8M Buy
39,047
+6,047
+18% +$278K 0.12% 112
2016
Q2
$1.66M Sell
33,000
-112
-0.3% -$5.63K 0.11% 108
2016
Q1
$1.77M Buy
33,112
+90
+0.3% +$4.82K 0.13% 97
2015
Q4
$2.17M Buy
33,022
+7,393
+29% +$485K 0.16% 72
2015
Q3
$581K Buy
25,629
+10,601
+71% +$240K 0.06% 285
2015
Q2
$888K Buy
15,028
+2,549
+20% +$151K 0.09% 179
2015
Q1
$777K Sell
12,479
-3,770
-23% -$235K 0.09% 191
2014
Q4
$935K Buy
16,249
+8,956
+123% +$515K 0.12% 141
2014
Q3
$392K Buy
7,293
+755
+12% +$40.6K 0.07% 277
2014
Q2
$343K Sell
6,538
-8,063
-55% -$423K 0.06% 304
2014
Q1
$771K Buy
14,601
+9,131
+167% +$482K 0.16% 104
2013
Q4
$219K Buy
5,470
+90
+2% +$3.6K 0.05% 368
2013
Q3
$203K Sell
5,380
-444
-8% -$16.8K 0.06% 331
2013
Q2
$228K Buy
+5,824
New +$228K 0.08% 245